Journey Medical Corp Files Definitive Proxy Statement
Ticker: DERM · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1867066
Sentiment: neutral
Topics: proxy-statement, annual-meeting, regulatory-filing
TL;DR
JMC filed its proxy statement for the June 24 meeting. Shareholders vote on key company matters.
AI Summary
Journey Medical Corporation filed a Definitive Proxy Statement (DEF 14A) on April 29, 2025, for its annual meeting on June 24, 2025. The company, based in Scottsdale, AZ, operates in the Pharmaceutical Preparations sector. This filing is a standard procedural document for soliciting shareholder votes.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the annual meeting, including any proposals to be voted on, and provides information on executive compensation and director nominations.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial information or strategic announcements that would inherently increase risk.
Key Players & Entities
- Journey Medical Corp (company) — Registrant
- April 29, 2025 (date) — Filing Date
- June 24, 2025 (date) — Meeting Date
- Scottsdale, AZ (location) — Company Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.
When is Journey Medical Corporation's annual meeting scheduled?
Journey Medical Corporation's annual meeting is scheduled for June 24, 2025.
What is the filing date of this proxy statement?
This Definitive Proxy Statement was filed on April 29, 2025.
Where is Journey Medical Corporation headquartered?
Journey Medical Corporation's business address is located at 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ 85258.
What industry does Journey Medical Corporation operate in?
Journey Medical Corporation operates in the Pharmaceutical Preparations industry, with SIC code 2834.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Journey Medical Corp (DERM).